Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › AADC polynucleotides for the treatment of Parkinson's disease

AADC polynucleotides for the treatment of Parkinson's disease

US Patent 11027000 · Granted Jun 8, 2021

Estimated economic value: $2,592,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Closed-ended DNA vectors obtainable from cell-free synthesis and process for obt2025
Protoparvovirus compositions comprising a protoparvovirus variant VP1 capsid pol2025
Methods for distributing high levels of therapeutic agent throughout the cortex 2025
Methods for biomedical targeting and delivery and devices and systems for practi2025
Compositions and methods for the treatment of Parkinson's disease2025
Compositions and methods for the treatment of Parkinson's disease2025
Therapeutic methods and compositions for treating movement disorders2025
Closed-ended linear duplex DNA for non-viral gene transfer2025
Chimeric capsids2024
AADC polynucleotides for the treatment of Parkinson's disease2024
AADC polynucleotides for the treatment of Parkinson's disease2024
AADC polynucleotides for the treatment of Parkinson's disease2024